CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE European Patent ...

Alys Pharmaceuticals, Inc. (“Alys”), an immune-dermatology focused company, today announces that the first patient has been dosed in its Phase IIa trial of ALY-101 in patients suffering from Alopecia ...

A groundbreaking study published in Climacteric has found that a combination of vaginal oxygen therapy and hyaluronic acid significantly improves lower urinary tract symptoms (LUTS) in breast cancer ...

Study27.03.2025 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study2,000+ Average-Risk ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that it has introduced its Medidata Site Insights Program, a ...

Informa Connect Life Sciences will hold its EU Pharmaceutical Law Forum May 20-22 at the Steigenberger Wiltcher's hotel in Brussels, Belgium. The EU Pharmaceutical Law Forum will host influencers ...

Chiesi Group, a global biopharmaceutical company headquartered in Parma, Italy, has announced a major investment in Nerviano (Milan, Italy), with the construction of a new facility for the production ...

UTC+8Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8MFirst-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical ...

Ellab, the leading provider of validation, monitoring, and calibration services and solutions, announces that it has appointed Gergely Sved as its new Chief Executive Officer (CEO), following the ...

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be appointed as the company’s new Chief Financial Officer, ...

Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, announces that it has secured over £140 million of acquisition ...

Annual ResultsGrünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US 27.03.2025 / 09:31 CET/CESTThe issuer is solely responsible for ...